Cambridge Nutritional Science
CNSL · AIM · Health Care · mcap £3.6m · 1.5p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 07 Oct 26 | Holding | Holding(s) in Company | |
| 06 Oct 26 | Holding | Holding(s) in Company | |
| 05 Oct 26 | Holding | Holding(s) in Company | |
| 01 Oct 26 | Holding | Holding(s) in Company | |
| 23 Sep 26 | Holding | Holding(s) in Company | |
| 22 Sep 26 | Holding | Holding(s) in Company | |
| 11 Sep 26 | Updated Notice of AGM
Updated Notice of AGM and Annual Report to 31 March 2026 |
+0.0% | |
| 08 Sep 26 | Routine | Notice of AGM & Annual Report to 31 March 2026 | |
| 08 Sep 26 | Results | Final Results
CNSL (AIM: CNSL), the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health, announces its audited results for the year ended 31 March 2026, a year that has s |
−24.3% |
| 17 Aug 26 | Updated Notice of Results & Investor Presentation
Updated Notice of Results & Investor Presentation via Investor Meet Company |
+0.0% | |
| 03 Aug 26 | Routine | Notice of Results & Investor Presentation | |
| 22 Apr 26 | Trading & Business Update
Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, is pleased to announce an update on the Comp |
+2.6% | |
| 31 Mar 26 | Holding | Holding(s) in Company | |
| 31 Mar 26 | Holding | Holding(s) in Company | |
| 19 Nov 25 | Director dealing | Director/PDMR Shareholding | |
| 10 Nov 25 | Results | Half-year Results
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025 |
−15.1% |
| 04 Nov 25 | Routine | Notice of Results & Investor Presentation |
Company filings. Not investment advice.